A phase 2 study of DS109 for the treatment of inflammatory skin disorders.
Phase of Trial: Phase II
Latest Information Update: 17 Jan 2017
At a glance
- Drugs Dihomo-gamma linolenic acid (Primary)
- Indications Skin disorders
- Focus Therapeutic Use
- 17 Jan 2017 New trial record
- 06 Jan 2017 According to a DS Biopharma media release, this trial is expected to start later this year.